Trial Profile
A Phase I, Open-Label,Single-Center Study Evaluating the Effects of Multiple Doses of Rifampicin on the Pharmacokinetics of a Single Oral Dose of Amenamevir in Healthy Male Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Nov 2017
Price :
$35
*
At a glance
- Drugs Amenamevir (Primary) ; Rifampicin
- Indications Herpes zoster
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Astellas Pharma
- 02 Nov 2017 New trial record
- 26 Oct 2017 Results published in the Advances in Therapy Journal.